Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Th-17 and the lack of efficacy of ustekinumab in pemphigus vulgaris.

Tirado-Sánchez A, Ponce-Olivera RM, Vazquez-González D, Bonifaz A.

Dermatol Online J. 2013 Mar 15;19(3):15.

2.

[Juvenile pemphigus vulgaris].

Janisson-Dargaud D, Reguiaï Z, Perceau G, Eschard C, Bernard P.

Ann Dermatol Venereol. 2008 Dec;135(12):843-7. doi: 10.1016/j.annder.2007.11.037. Epub 2008 Aug 29. French.

PMID:
19084695
3.
4.

Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.

Daneshpazhooh M, Chams-Davatchi C, Khamesipour A, Mansoori P, Taheri A, Firooz A, Mortazavi H, Esmaili N, Dowlati Y.

J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1319-24.

PMID:
17958835
5.

[Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].

España Alonso A, Panizo C, Fernández S, Marquina M, Pretel M, Aguado L, Sánchez-Ibarrola A.

Actas Dermosifiliogr. 2009 Mar;100(2):113-20. Spanish.

PMID:
19445875
6.

Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.

Hallaji Z, Mortazavi H, Lajevardi V, Tamizifar B, AmirZargar A, Daneshpazhooh M, Chams-Davatchi C.

J Eur Acad Dermatol Venereol. 2010 Mar;24(3):275-80. doi: 10.1111/j.1468-3083.2009.03408.x. Epub 2009 Aug 26.

PMID:
19709345
7.

[Intravenous immunoglobulin therapy: ELISA measurement of antidesmogleins 1 and 3 in three patients with pemphigus vulgaris].

Suárez-Fernández R, Longo I, Avilés JA, Bueno C, Rodríguez-Mahou M, Lázaro P.

Rev Clin Esp. 2006 Nov;206(10):499-503. Spanish.

PMID:
17129517
8.

Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia?

Laffitte E, Panizzon RG, Borradori L.

Dermatology. 2008;217(4):337-9. doi: 10.1159/000155645. Epub 2008 Sep 18.

PMID:
18799879
9.

Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance.

Kamiya K, Aoyama Y, Shirafuji Y, Hamada T, Morizane S, Fujii K, Hisata K, Iwatsuki K.

Br J Dermatol. 2012 Aug;167(2):252-61. doi: 10.1111/j.1365-2133.2012.10929.x. Epub 2012 Jun 11.

PMID:
22404487
10.

Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.

Tabuchi K, Nomura M, Murashita H, Fujisawa Y, Tsuji S, Okubo H, Hara A.

Auris Nasus Larynx. 2006 Jun;33(2):231-3. Epub 2005 Sep 15.

PMID:
16168587
11.

Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.

Reguiai Z, Tabary T, Maizières M, Bernard P.

J Am Acad Dermatol. 2012 Oct;67(4):623-9. doi: 10.1016/j.jaad.2011.12.019. Epub 2012 Jan 20.

PMID:
22261417
12.
13.

Cytokine networks in Pemphigus vulgaris: An integrated viewpoint.

Giordano CN, Sinha AA.

Autoimmunity. 2012 Sep;45(6):427-39. doi: 10.3109/08916934.2012.697593. Epub 2012 Jul 13. Review.

PMID:
22686612
14.

IgG/IgA pemphigus with IgG and IgA antidesmoglein 3 antibodies and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay: a case report and review of the literature.

Zaraa I, Kerkeni N, Sellami M, Chelly I, Zitouna M, Makni S, Mokni M, Ben Osman A.

Int J Dermatol. 2010 Mar;49(3):298-302. doi: 10.1111/j.1365-4632.2009.04195.x. Review. No abstract available.

PMID:
20465668
15.

Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.

Cassano N, Mastrandrea V, Tampoia M, Filotico R, Vestita M, Vena GA.

J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):197-201. Review.

PMID:
19828097
16.
17.

Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.

Nagel A, Lang A, Engel D, Podstawa E, Hunzelmann N, de Pita O, Borradori L, Uter W, Hertl M.

Clin Immunol. 2010 Mar;134(3):320-30. doi: 10.1016/j.clim.2009.11.006. Epub 2009 Dec 16.

PMID:
20015693
18.

Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.

Eming R, Rech J, Barth S, Kalden JR, Schuler G, Harrer T, Hertl M.

Dermatology. 2006;212(2):177-87.

PMID:
16484825
19.

Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.

Cheng SW, Kobayashi M, Kinoshita-Kuroda K, Tanikawa A, Amagai M, Nishikawa T.

Br J Dermatol. 2002 Aug;147(2):261-5.

PMID:
12174096
20.

Pemphigus vulgaris treated with adalimumab: case study.

Vojáčková N, Fialová J, Vaňousová D, Hercogová J.

Dermatol Ther. 2012 Jan-Feb;25(1):95-7. doi: 10.1111/j.1529-8019.2012.01433.x.

PMID:
22591504
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk